Abstract
Objectives
To longitudinally assess the value of cardiac functional and viability imaging as a supplement to MR angiography in patients with atherosclerotic disease.
Methods
Cardiac MRI was performed in 195 consecutive patients with symptomatic peripheral arterial disease. Of these, 186 patients were followed for 22 ± 5 months for the presence of cardiac events (cardiac death, acute coronary syndrome and hospitalisation as a result of congestive heart failure).
Results
Myocardial viability imaging showed a high prevalence of known (n = 31) and occult myocardial infarctions (MI) (n = 26). Cardiac events occurred more often in patients with reduced ventricular function (ejection fraction (EF) less than 40%, cardiac event in 4/8 patients; EF 40–55%, cardiac event in 10/40 patients; EF greater than 55%, cardiac event in 15/138 patients) as well as in patients with occult MI (8/25 patients) and known MI (11/30 patients). In patients with normal function, the detection of a previous MI was of high relevance to prognosis.
Conclusions
Both reduced EF and the presence of MI influence patients’ prognoses. Performing cardiac MRI in this patient population may influence further patient management including intensified risk factor intervention.
Similar content being viewed by others
References
Ross R (1999) Atherosclerosis—an inflammatory disease. N Engl J Med 340:115–126
Leng GC, Lee AJ, Fowkes FG et al (1996) Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int J Epidemiol 25:1172–1181
Kioka Y, Tanabe A, Kotani Y et al (2002) Review of coronary artery disease in patients with infrarenal abdominal aortic aneurysm. Circ J 66:1110–1112
Seeger A, Grimm F, Fenchel M et al (2008) Cardiac MRI in addition to MR angiography: a longitudinal study in vascular risk patients. Rofo 180:423–429
White HD, Norris RM, Brown MA et al (1987) Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 76:44–51
Ross DL, Davis KB, Pettinger MB et al (1987) Features of cardiac arrest episodes with and without acute myocardial infarction in the Coronary Artery Surgery Study (CASS). Am J Cardiol 60:1219–1224
Kannel WB, Cupples LA, Gagnon DR (1990) Incidence, precursors and prognosis of unrecognized myocardial infarction. Adv Cardiol 37:202–214
Kwong RY, Chan AK, Brown KA et al (2006) Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation 113:2733–2743
Kannel WB, Abbott RD (1984) Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study. N Engl J Med 311:1144–1147
Cox CJ (1967) Return to normal of the electrocardiogram after myocardial infarction. Lancet 1:1194–1197
Prince MR (1998) Contrast-enhanced MR angiography: theory and optimization. Magn Reson Imaging Clin N Am 6:257–267
Fenchel M, Scheule AM, Stauder NI et al (2006) Atherosclerotic disease: whole-body cardiovascular imaging with MR system with 32 receiver channels and total-body surface coil technology—initial clinical results. Radiology 238:280–291
Miller S, Simonetti OP, Carr J et al (2002) MR Imaging of the heart with cine true fast imaging with steady-state precession: influence of spatial and temporal resolutions on left ventricular functional parameters. Radiology 223:263–269
Dulce MC, Mostbeck GH, Friese KK et al (1993) Quantification of the left ventricular volumes and function with cine MR imaging: comparison of geometric models with three-dimensional data. Radiology 188:371–376
Thiele H, Paetsch I, Schnackenburg B et al (2002) Improved accuracy of quantitative assessment of left ventricular volume and ejection fraction by geometric models with steady-state free precession. J Cardiovasc Magn Reson 4:327–339
Mahrholdt H, Wagner A, Judd RM et al (2005) Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J 26:1461–1474
Cerqueira MD, Weissman NJ, Dilsizian V et al (2002) Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105:539–542
Gordon T, Kannel WB (1972) Predisposition to atherosclerosis in the head, heart, and legs. The Framingham study. JAMA 221:661–666
Criqui MH, Langer RD, Fronek A et al (1992) Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 326:381–386
Leng GC, Lee AJ, Fowkes FG et al (1996) Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int J Epidemiol 25:1172–1181
CAPRIE (1996) A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events. CAPRIE Steering Committee. Lancet 348:1329–1339
Diehm C, Schuster A, Allenberg JR et al (2004) High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study. Atherosclerosis 172:95–105
Dormandy JA, Rutherford RB (2000) Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg 31:S1–S296
Sheifer SE, Gersh BJ, Yanez ND et al (2000) Prevalence, predisposing factors, and prognosis of clinically unrecognized myocardial infarction in the elderly. J Am Coll Cardiol 35:119–126
Kwong RY, Sattar H, Wu H et al (2008) Incidence and prognostic implication of unrecognized myocardial scar characterized by cardiac magnetic resonance in diabetic patients without clinical evidence of myocardial infarction. Circulation 118:1011–1020
Ricciardi MJ, Wu E, Davidson CJ et al (2001) Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation. Circulation 103:2780–2783
Kim RJ, Fieno DS, Parrish TB et al (1999) Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 100:1992–2002
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Seeger, A., Fenchel, M., Kramer, U. et al. Towards risk stratification in systemic atherosclerosis: value of myocardial function and viability imaging as an adjunct to MR angiography. Eur Radiol 20, 838–845 (2010). https://doi.org/10.1007/s00330-009-1607-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-009-1607-z